Atlas Trials

MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Clinical trial NCT03585764 · TERMINATED

Trial details

NCT number
NCT03585764
Sponsor
University of Pennsylvania
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Start date
2018-10-24
Primary completion
2024-03-26
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.